A003060 Stock Overview
Manufactures and sells pharmaceutical products primarily in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Aprogen Biologics Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩764.00 |
| 52 Week High | ₩3,230.00 |
| 52 Week Low | ₩702.00 |
| Beta | -0.0088 |
| 11 Month Change | -4.50% |
| 3 Month Change | -24.80% |
| 1 Year Change | -75.03% |
| 33 Year Change | -91.32% |
| 5 Year Change | -93.12% |
| Change since IPO | -99.91% |
Recent News & Updates
Risks Still Elevated At These Prices As Aprogen Biologics Inc. (KRX:003060) Shares Dive 26%
Jun 20
More Unpleasant Surprises Could Be In Store For Aprogen Biologics Inc.'s (KRX:003060) Shares After Tumbling 28%
Apr 18Recent updates
Risks Still Elevated At These Prices As Aprogen Biologics Inc. (KRX:003060) Shares Dive 26%
Jun 20More Unpleasant Surprises Could Be In Store For Aprogen Biologics Inc.'s (KRX:003060) Shares After Tumbling 28%
Apr 18We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide
Jan 16Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Dec 20
Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?
Nov 24Shareholder Returns
| A003060 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 7.3% | -3.1% | 2.9% |
| 1Y | -75.0% | 4.8% | -2.8% |
Return vs Industry: A003060 underperformed the KR Pharmaceuticals industry which returned 4.8% over the past year.
Return vs Market: A003060 underperformed the KR Market which returned -2.8% over the past year.
Price Volatility
| A003060 volatility | |
|---|---|
| A003060 Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A003060 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A003060's weekly volatility has decreased from 11% to 6% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1960 | 363 | Jeong-Chool Kim | en.aprogen-pharm.com/index.do |
Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss.
Aprogen Biologics Inc. Fundamentals Summary
| A003060 fundamental statistics | |
|---|---|
| Market cap | ₩147.19b |
| Earnings (TTM) | -₩141.77b |
| Revenue (TTM) | ₩68.03b |
2.2x
P/S Ratio-1.1x
P/E RatioIs A003060 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A003060 income statement (TTM) | |
|---|---|
| Revenue | ₩68.03b |
| Cost of Revenue | ₩71.66b |
| Gross Profit | -₩3.63b |
| Other Expenses | ₩138.15b |
| Earnings | -₩141.77b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -717.58 |
| Gross Margin | -5.33% |
| Net Profit Margin | -208.39% |
| Debt/Equity Ratio | 24.5% |
How did A003060 perform over the long term?
See historical performance and comparison